Skip to main content

Author: Tom Wilemon

Grant enhances study of new chemotherapy targets

Oct. 18, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Cancer Center investigators awarded Komen grants

Oct. 11, 2018—Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

Read more


VICC’s Levy to lead Rush University Cancer Center

Oct. 4, 2018—Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.

Read more


Cochran celebrates cancer treatment’s end in style

Oct. 4, 2018—Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father.

Read more


New study looks at brain networks involved in free will

Oct. 3, 2018—Using lesion network mapping, a recently developed technique for analyzing how the brain works, Ryan Darby, MD, assistant professor of Neurology at Vanderbilt, studied free will perception related to movement decisions.

Read more


Cancer Moonshot award to help map tumor progression

Sep. 27, 2018—A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

Read more


Team’s potential lung cancer therapy lands award from SBIR

Sep. 27, 2018—A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

Read more


Chic Awearness event supports VUMC ovarian cancer research

Sep. 20, 2018—The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.

Read more


CDC releases new mild traumatic brain injury guideline

Sep. 20, 2018—The Centers for Disease Control and Prevention released new clinical recommendations for health care providers treating children with mild traumatic brain injury, often referred to as concussion.

Read more


Study tracks incidence, timing of immunotherapy-related deaths

Sep. 13, 2018—Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Read more


Major award seeks to improve stroke outcomes

Aug. 30, 2018—Vanderbilt’s Kenneth Gaines, MD, MBA, professor of Clinical Neurology, has received a $15.7 funding award to determine if stroke outcomes can be improved with a redesigned and better-integrated model of care.

Read more


Parkinson’s study to track impact of DBS on earliest patients

Aug. 30, 2018—A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.

Read more


Page 1 of 1112345678...Last »

Recent Stories from VUMC News and Communications Publications

Our amazing skin

Vanderbilt Medicine

Our amazing skin

Biology and the beat

Vanderbilt Medicine

Biology and the beat

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

more